Stratos Wealth Advisors, LLC Immuno Gen, Inc. Transaction History

Stratos Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$2.25 - $5.8 $28,437 - $73,306	-12,639 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.22 - $3.39 $279 - $427	-126 Reduced 0.99%	12,639 $31,000
Q2 2019 Aug 06, 2019	SELL	$1.8 - $3.3 $2,266 - $4,154	-1,259 Reduced 8.98%	12,765 $28,000
Q1 2019 May 07, 2019	BUY	$2.41 - $5.91 $33,797 - $82,881	14,024 New	14,024 $38,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.